Abstract
This presentation was given at the ACIP extraordinary meeting on January 27th.
It includes an update on
- AZD1222 Adenoviral Platform, Clinical Development Plan & Phase I/II
- Data US Phase III Study
- Non-IND Phase III Efficacy and Safety Trials (Interim Analysis)
- Vaccine Storage & Handling
- Summary
Background paper
Americas
United States of America
AstraZeneca COVID-19 vaccine
COVID-19
